Sarah Ford | January 28, 2014

Google Is Developing Contact Lenses to Measure Glucose Levels for People With Diabetes

Source: Insulin Nation

By Craig Idlebrook

Google has announced the development of contact lenses that can measure glucose levels! The tech giant has put an end to fingerpricks forever! Let the ticker-tape parade begin!

Wait, no. Let’s take a deep breath.

The name “Google” brings to mind futuristic tech advancements that can revolutionize life as we know it. After all, the company dominates search engine technology and cute cat videos, is on track to develop the first commercially-sold self-driving car, and seemingly has more money to spend than many industrialized nations. Having mastered the Internet, the company is turning its attention to the one sector of our economy with the most growth potential: health care.

Last year, Google made a few diabetes-related headlines when it announced it was throwing a few million dollars at a company working to develop oral insulin (see “Google Plus Oral Insulin”). And now its secretive “Google X” division has announced it has developed a contact lens that can measure glucose. When Google talks about diabetes, people listen.

The Google X blogpost announcement sounds promising, describing “a smart contact lens that’s built to measure glucose levels in tears using a tiny wireless chip and miniaturized glucose sensor that are embedded between two layers of soft contact lens material.” The developers say it can measure a reading per second, and may even come with built-in early warning devices to warn a wearer of fluctuations in BG levels. All good stuff.

But if you peek past the headlines, it becomes apparent that this device is still in the beginning stages of development. Clinical trials are underway and Google is in “discussions” with the FDA, but there really is no definitive timeline for when, or if, this product will make it to market. FDA approval is notoriously slow for any novel diabetes treatment device, as well; Mannkind hopes 2014 is the year for its inhalable insulin device to gain FDA approval after years of regulatory limbo, but no one is holding their breath. Also absent from the post is any mention of accuracy. It’s great if this device can measure glucose, but it’s more important that it measure glucose accurately.

>> Continue Reading

Get Resources and Insights Straight To Your Inbox

Explore More Articles

Women’s Health Month

April 8, 2024

May is Women’s Health Month, a time when we focus on the importance of taking care of ourselves and our health. This month is an…

Read Article

Military Spouse Appreciation Day

April 8, 2024

May 10 marks the celebration of Military Spouse Appreciation Day, a time to honor and recognize the immense contributions made by military spouses in supporting…

Read Article

Melanoma and Skin Cancer Awareness Month

April 8, 2024

Melanoma is an aggressive form of skin cancer. In addition to the skin, melanoma may also occur in mucous membranes – thin, moist layers of tissue that cover surfaces…

Read Article

Get Resources and Insights Straight To Your Inbox

Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.